UpdatesPress Release
Anlon Healthcare reported strong Q1FY27 results with 163% revenue growth to ₹87.62 Cr and 133% PAT growth to ₹8.28 Cr.
Anlon Healthcare LimitedAHCL · Filed with the exchange
The company expanded into Finished Dosage Formulations via subsidiary acquisition.
No comments yet. Be the first.